Therapeutic Targeting of BAP1/ASXL3 Sub-complex in ASCL1-Dependent Small Cell Lung Cancer

0
86
Researchers investigated the function of the oncogenic BAP1/ASXL3/BRD4 epigenetic axis in small cell lung cancer by developing a next-generation BAP1 inhibitor.
[Oncogene]
Full Article